Leading Justice is a full-service marketing company working with law firms on a cash buy basis to sign up fully-qualified, fraud-free Tylenol cases. Here at Leading Justice, we can customize your firm’s Tylenol advertising needs and help you sign up cases via internal cash buys. Our clients simply pay an agency fee to cover the cost of Tylenol advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. We also cross-qualify all of our contacts, which means any data we generate that isn’t eligible for the target campaign is reevaluated to determine if it qualifies for another type of claim. By using innovative approaches to target contacts specifically related to Tylenol and liver failure side effects, Leading Justice will increase your firm’s Tylenol liver failure case load. If you are interested in helping victims of alleged Tylenol side effects, our extensive consumer reach and direct advertising strategies at Leading Justice give you the competitive edge and confidence you need to allocate your full budget, and rest easy knowing your money is being used the best way possible.
Each law firm we work with at Leading Justice has a direct impact on how we classify claims as qualified or not. And while our experience working with plaintiff law firms helps us recognize a great case when we see one, we will customize our Tylenol liver failure case intake specifications to the exact criteria you are seeking. So, if your firm has certain Tylenol qualifying case criteria you would like us to use, we will train our intake specialists to apply the criteria to every phone call and email they receive. By getting rid of the middle man, Leading Justice offers clients an opportunity for internal cash buys of Tylenol data with zero chance of fraud.
Our Take on Tylenol Liver Failure
Despite the fact that Tylenol has been on the market for decades and is considered one of the most trusted brands in America, studies show that using the over-the-counter pain reliever may significantly increase a patient’s risk of suffering potentially fatal side effects like liver failure. In fact, according to the FDA, Tylenol or acetaminophen-related overdoses result in approximately 56,000 emergency room visits, 26,000 hospitalizations and 458 deaths every year. Unfortunately, many people who take Tylenol and other acetaminophen-containing medications are unaware of the complications potentially linked to the pain reliever, and therefore may be at risk for liver damage, liver failure or possibly even death.
Since details first began to emerge about the risk of Tylenol overdose and liver failure, many lawsuits have been filed against Johnson & Johnson, claiming that the pharmaceutical giant failed to adequately warn patients about potential Tylenol side effects. In January 2011, the FDA required all makers of prescription drugs containing acetaminophen to include boxed warnings highlighting the risk of liver injury side effects. Since then, Johnson & Johnson has reduced the maximum daily recommended dose of Tylenol from 4,000 mg to 3,000 mg in an effort to reduce the chances of Tylenol liver injury. Despite these actions, Tylenol users throughout the country continue to be at unnecessary risk.